Q/C Technologies, Inc. Derivative Liability, Current
Q/C Technologies, Inc. (QCLS) had Derivative Liability, Current of $1.57 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Derivative Liability, Current $1.57M.
- 2026-03-31: Derivative Liability, Current $1.65M.
- 2025-12-31: Derivative Liability, Current $2.16M.
- 2025-09-30: Derivative Liability, Current $2.90M.
| Period end | Derivative Liability, Current |
|---|---|
| 2026-06-30 | $1.57M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.65M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.16M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $2.90M 10-Q · filed 2025-11-19 |
| 2025-03-31 | $19.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.30M 10-K · filed 2026-04-15 |
| 2024-09-30 | $1.28M 10-Q · filed 2024-11-14 |
| 2023-12-31 | $61.00K 10-K · filed 2025-04-11 |
| 2023-09-30 | $898.10K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |